Zileuton - Isotope Labelled Standards
References
FAQ's
References
- Summers, James B., Jr.; Gunn, Bruce P.; Brooks, Dee W., Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds, Abbott Laboratories, United States, EP0279263A2, August 24, 1988
- Pian, Phillip; Labovitz, Edward; Hoffman, Keith; Clavijo, Claudia F.; Rzasa Lynn, Rachael; Galinkin, Jeffrey L.; Vinks, Alexander A.; Malik, Punam; Christians, Uwe, Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Volume: 937, Pages: 79-83, 2013
Frequently Asked Questions
Are there regulatory limits for Zileuton impurities?
Regulatory authorities establish limits for impurities in pharmaceutical products, including Zileuton. These limits define the acceptable impurity levels considered safe for human consumption.
How are Zileuton impurities evaluated?
Zileuton impurities are evaluated through comprehensive testing with analytical methods and techniques such as Ultra-High-Pressure Liquid Chromatography.
How should Zileuton impurities be stored in terms of temperature?
The recommendation is to store Zileuton impurities at room temperature, within 2-8 °C.
Which solvent helps in the analysis of Zileuton impurities?
Methanol is the solvent used in analyzing many impurities in Zileuton.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.